Way2AR conducted a customer development experiment where a startup narrowed its focus to one market after five days.

Way2AR develops cutting-edge immersive technology solutions—including augmented reality (AR), mixed reality (MR), and interactive 3D formats—to transform medical education, pharmaceutical marketing, and healthcare professional (HCP) engagement. We enable pharmaceutical companies to deliver engaging, scientifically precise interactions with HCPs, enhancing both comprehension and retention of key medical information. Way2AR develops advanced solutions at the intersection of AI and immersive technologies. As the developer of EvaAI, we apply our expertise to building innovative digital products in healthcare engagement and AI-driven mental health support, shaping the future of medical technology. Seamlessly integrated into existing workflows, our technologies require no disruption to traditional detailing approaches, making them a natural and effective addition to current engagement strategies. Expertise & Track Record With 7+ years of experience in digital media and IT, our team has been pioneering AR/VR applications in Pharma for over four years. We have successfully delivered 120+ projects, demonstrating a deep understanding of how to design, implement, and scale high-impact immersive content that delivers measurable results for pharmaceutical brands. Trusted by Industry Leaders Our client portfolio includes Pfizer, Boehringer Ingelheim, Novo Nordisk, Splat, Electrolux, University of Copenhagen, Fresenius Kabi, Unipharm, Biomed, and many others. At Way2AR, we believe innovation is not just about technology—it’s about creating meaningful experiences that drive better engagement, learning, and outcomes.